Sequent Scientific Limited
Ranjit Suryawanshi has an extensive work history in the pharmaceutical industry. Ranjit most recently served as the Site Head at Sequent Scientific Limited starting in 2023. Prior to that, they worked as a General Manager at Torrent Pharmaceuticals Ltd from 2018 to 2023. Ranjit also held positions as a Sr General Manager at SUPRIYA LIFESCIENCE LIMITED from 2015 to 2018, a Senior General Manager at Harman Finochem Ltd for a brief period in 2015, and as a Sr.General Manager (Operations) at Nector Life sciences Ltd from 2012 to 2015.
Before these roles, Ranjit served as the General Manager Works at Indoco Remedies Ltd from 2009 to 2012, and as an Assistant General Manager at Cipla from 2007 to 2008. Ranjit also worked as a Production Manager at Glenmark Pharmaceuticals from 2002 to 2006, a Production Executive at Rallis India Ltd from 1997 to 2002, and a Production Officer at Ipca Laboratories Limited from 1994 to 1997.
Ranjit Suryawanshi earned a degree in Industrial Chemistry from SB High school. The specific start and end years of their education are not provided.
This person is not in any teams
This person is not in any offices
Sequent Scientific Limited
4 followers
SeQuent Scientific Limited is India’s largest and amongst the ‘Top 20’ global animal health companies, backed by global investment firm ‘The Carlyle Group’ as the promoter. The company has 8 manufacturing facilities across Europe, Turkey, Brazil & India with the Vizag site being India’s only USFDA approved dedicated veterinary API facility. SeQuent offers a comprehensive portfolio of finished drug formulations, active pharmaceutical ingredients along with analytical services, which address the needs of the global animal health sector.